Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
84 hedge funds and large institutions have $16M invested in Avid Bioservices, Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 29 increasing their positions, 19 reducing their positions, and 17 closing their positions.
692% more call options, than puts
Call options by funds: $103K | Put options by funds: $13K
53% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 19
10% less funds holding
Funds holding: 93 → 84 (-9)
41% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 17
63% less capital invested
Capital invested by funds: $42.8M → $16M (-$26.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.88M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$490K |
| 3 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
+$463K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$444K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$169K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.27M |
| 2 |
IHM
Iguana Healthcare Management
New York
|
-$585K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$424K |
| 4 |
NC
Nexthera Capital
New York
|
-$287K |
| 5 |
Morgan Stanley
New York
|
-$201K |
CDMO Hedge Fund Activity: Q1 2016 in Review
84 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q1 2016, worth a combined $16M — down 63% from $42.8M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of CDMO and 10 opened new positions — a net loss of 7 holders — while 19 trimmed existing stakes and 29 added.
The largest buyer was Vanguard Group, adding an estimated $1.88M. The largest seller was Millennium Management, exiting entirely with an estimated $1.27M sold.
- 84 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q1 2016, down from 93 in Q4 2015.
- Funds reported $16M of Avid Bioservices, Inc. Common Stock stock for Q1 2016, down 63% quarter-over-quarter.
- 10 funds opened new Avid Bioservices, Inc. Common Stock positions in Q1 2016 and 17 closed out, a net change of -7 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q1 2016 was Vanguard Group, an estimated $1.88M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q1 2016 was Millennium Management, an estimated $1.27M sold.
Based on aggregated 13F filings for Q1 2016.